Jiayuan Technology: granted 1975300 restricted shares to 163 incentive objects

Synthetic Biology: Who Will Emerge as the Winner?

The 21st century is the century of biology. Synthetic biology is believed to be a ‘World Changing’ industry. But the potential risks like cost control and commercialization pathways are fatefully tied to the ups and downs of countless investment decisions and the destiny of the many new start-ups getting involved. We look forward to seeing an emerging ‘giant’ on the horizon of this exciting industry.

People's Bank of China Announces Reserve Requirement Ratio and Interest Rate Cuts

People's Bank of China has rolled out a package of monetary policy measures to stabilize the market and expectations

Chinese AI Technology Firm Kunlun Tech's 2024 Revenue Exceeds CNY 5.6 Billion

Chinese AI Technology Corporation Kunlun Tech emerges as China's fastest-growing AI company in overseas revenue for 2024

Auto Shanghai 2025 - Nullmax Showcases Full-Stack Automated Driving Solutions

On April 23rd, the biennial Shanghai International Automobile Industry Exhibition kicked off grandly. Nullmax, an AI technology company specializing in AD/ADAS solutions for all scenarios, presented its self-developed full-stack MaxDrive solutions. These solutions range from active safety features to autonomous driving solution for urban scenario based on end-to-end technical architecture, catering to the diverse needs of different vehicle models and markets.

Bloomage: Injecting Biotechnology into Beauty Care

Listed on the Chinese Star Market in November 2019, Bloomage was trading at CNY 138.01 as of June 24, 2020, over 38% higher than the IPO price of CNY 100.